Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.76 USD | +1.16% | +3.89% | +52.71% |
May. 28 | Nurix Therapeutics, Inc. Appoints Paula G. O?Connor as Chief Medical Officer and Pasit Phiasivongsa as Chief Technical Officer | CI |
May. 20 | Nurix Therapeutics Names New Board Chair | MT |
Financials (USD)
Sales 2024 * | 71.27M | Sales 2025 * | 66.83M | Capitalization | 934M |
---|---|---|---|---|---|
Net income 2024 * | -171M | Net income 2025 * | -221M | EV / Sales 2024 * | 8.95 x |
Net cash position 2024 * | 297M | Net cash position 2025 * | 297M | EV / Sales 2025 * | 9.54 x |
P/E ratio 2024 * |
-5.34
x | P/E ratio 2025 * |
-4.74
x | Employees | 284 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.82% |
1 day | +1.16% | ||
1 week | +3.89% | ||
Current month | +0.06% | ||
1 month | +20.49% | ||
3 months | +16.22% | ||
6 months | +128.08% | ||
Current year | +52.71% |
Managers | Title | Age | Since |
---|---|---|---|
Arthur Sands
CEO | Chief Executive Officer | 62 | 14-09-17 |
Hans van Houte
DFI | Director of Finance/CFO | 58 | 14-12-31 |
Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Judith Reinsdorf
BRD | Director/Board Member | 60 | 21-09-30 |
Paul Silva
BRD | Director/Board Member | 58 | 21-09-30 |
Arthur Sands
CEO | Chief Executive Officer | 62 | 14-09-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.70% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 15.75 | +1.09% | 1,879,787 |
24-05-30 | 15.58 | +3.11% | 685,374 |
24-05-29 | 15.11 | -2.77% | 464,032 |
24-05-28 | 15.54 | +2.44% | 579,402 |
24-05-24 | 15.17 | -.--% | 530,542 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.71% | 934M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- NRIX Stock